Bin Li

The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.

Baldur P Magnusson, David T. Barkan, Christopher T. Jones, 2018, Clinical therapeutics.

A Multi-Centre Prospective Study of the Efficacy and Safety of Alglucosidase Alfa in Chinese Patients With Infantile-Onset Pompe Disease

Benzhen Wang, Guangsong Shan, Zipu Li, 2022, Frontiers in Pharmacology.

Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

G. Wang, W. Wang, Hao Li, 2020, Phytomedicine.

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Ke Huang, Xue-Qun Luo, Jie Luo, 2018, American journal of hematology.

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

Yue Liu, Hao Li, Zhixu Yang, 2021, Phytomedicine.